Healthcare -
Biotechnology - NASDAQ - NL
$ 40.03
-9.03 %
$ 2.77 B
Market Cap
-11.77
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Merus N.V.
| Net Income | -215 M |
| Depreciation & Amortization | 2.47 M |
| Capital Expenditures | -1.67 M |
| Stock-Based Compensation | 45.8 M |
| Change in Working Capital | 24.3 M |
| Others | -19.4 M |
| Free Cash Flow | -188 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (215.3) | (154.9) | (131.2) | (66.8) | (85.5) | (55.2) | (27.8) | (87.7) | (49.7) | (25.3) | (21.2) | (13.7) |
| Depreciation & Amortization | 2.5 | 2.5 | 1.3 | 1.5 | 1.4 | 1.1 | 0.7 | 0.4 | 0.2 | 0.2 | 0.3 | 0.4 |
| Deferred Income Tax | (0.3) | 0.8 | (1.6) | 7 K | (0.1) | 89 K | (7.1) | 31.6 | 20.5 | (0.2) | 47.4 K | 75.9 K |
| Stock Based Compensation | 45.8 | 26.2 | 24.5 | 17.1 | 9.4 | 7.8 | 9.1 | 15.4 | 3.5 | 0.6 | 0.2 | 0.3 |
| Other Operating Activities | (42.8) | 8.9 | (23.9) | (27.3) | 9.0 | (1.6) | (1.4) | (1.2) | 34.7 K | 0.2 | 13.4 K | 2.76 K |
| Change in Working Capital | 24.3 | (25.8) | (19.0) | 15.9 | (14.1) | (15.2) | (19.9) | (3.3) | (1.6) | (0.6) | 3.0 | 3.5 |
| Cash From Operations | (185.8) | (142.2) | (149.9) | (59.6) | (79.9) | (63.0) | (46.3) | (44.9) | (27.1) | (25.2) | (17.7) | (9.6) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (1.7) | (4.0) | (7.6) | (0.9) | (1.3) | (2.6) | (4.2) | (0.9) | (0.5) | (0.1) | (0.2) | (0.1) |
| Other Items | (218.6) | (23.0) | 10.4 | (145.8) | (0.2) | 26.8 | (18.0) | (49.1) | 92.5 K | 54.7 K | 86.3 K | 0.1 |
| Cash From Investing Activities | (220.2) | (27.0) | 2.8 | (146.6) | (1.5) | 24.2 | (22.2) | (49.9) | (0.4) | 57.9 K | (0.1) | 6.9 K |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.6) | (0.2) | 8.6 | (0.2) | (0.2) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 36.5 | 4.1 | 1.0 | 16.8 | 1.4 | 48 K | (7.0) | 134.3 | (0.2) | 60.1 K | (1.1) | 0.651 |
| Cash From Financing Activities | 494.0 | 230.1 | 58.7 | 282.0 | 39.5 | 74.2 | 59.0 | 223.4 | 52.8 | 59.4 | 7.1 | 16.4 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 89.0 | 56.6 | (93.3) | 78.5 | (34.5) | 33.1 | (6.8) | 111.3 | 25.3 | 34.2 | (10.7) | 6.7 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (187.5) | (146.2) | (157.5) | (60.5) | (81.2) | (65.6) | (50.5) | (45.8) | (27.6) | (25.3) | (17.9) | (9.7) |